In silico analysis and preclinical findings uncover potential targets of anti-cervical carcinoma and COVID-19 in laminarin, a promising nutraceutical

Jiaqi Liu, Yudong Chen, Litao Nie, Liang Xiao, Wenjun Huang, Rong LiFrontiers in Pharmacology 2022 · DOI

Abstract

Until today, the coronavirus disease 2019 (COVID-19) pandemic has caused 6,043,094 deaths worldwide, and most of the mortality cases have been related to patients with long-term diseases, especially cancer. Autophagy is a cellular process for material degradation. Recently, studies demonstrated the association of autophagy with cancer development and immune disorder, suggesting autophagy as a possible target for cancer and immune therapy. Laminarin is a polysaccharide commonly found in brown algae and has been reported to have pharmaceutic roles in treating human diseases, including cancers. In the present report, we applied network pharmacology with systematic bioinformatic analysis, including gene ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, reactome pathway analysis, and molecular docking to determine the pharmaceutic targets of laminarin against COVID-19 and cervical cancer via the autophagic process. Our results showed that the laminarin would target ten genes: CASP8, CFTR, DNMT1, HPSE, KCNH2, PIK3CA, PIK3R1, SERPINE1, TLR4, and VEGFA. The enrichment analysis suggested their involvement in cell death, immune responses, apoptosis, and viral infection. In addition, molecular docking further demonstrated the direct binding of laminarin to its target proteins, VEGFA, TLR4, CASP8, and PIK3R1. The present findings provide evidence that laminarin could be used as a combined therapy for treating patients with COVID-19 and cervical cancer.

Introduction

The COVID-19 pandemic highlighted a critical vulnerability in patients with pre-existing conditions, particularly malignancy. Individuals with cervical cancer face significantly higher risks of severe outcomes from viral infection. Consequently, there is an urgent need for multi-target therapeutic agents that can simultaneously address tumor progression and modulate the immune response.

This study focuses on autophagy, a cellular degradation mechanism that maintains homeostasis. Dysfunctional autophagy is a common denominator in both cancer development and the viral hijacking of host cells by SARS-CoV-2. Laminarin, a biocompatible polysaccharide derived from brown algae, emerges as a promising candidate for regulating these overlapping pathways due to its known anti-tumor and immunomodulatory properties.

Methods

The researchers employed an in silico network pharmacology approach to map the complex interactions between laminarin and its potential biological targets.

Target Identification and Bioinformatic Analysis

The study integrated transcriptomic data from the Gene Expression Omnibus (GSE63514), comparing mRNA profiles of normal and cervical cancer tissues. Differentially expressed genes (DEGs) were cross-referenced with COVID-19 and autophagy-related gene sets obtained from GeneCards, OMIM, and NCBI. Potential targets for laminarin itself were predicted using databases such as the Comparative Toxicogenomics Database (CTD) and Swiss Target Prediction.

Pathway Enrichment and Protein Interaction

Gene Ontology (GO) and KEGG pathway analyses were performed to identify the biological processes and signaling pathways involved. A Protein-Protein Interaction (PPI) network was constructed using the STRING database and visualized via Cytoscape to identify core hub genes.

Molecular Docking

To validate physical interactions, molecular docking simulations were conducted using AutoDock Vina. The 3D structures of key target proteins (VEGFA, TLR4, CASP8, and PIK3R1) were retrieved from the Protein Data Bank (PDB) to calculate binding affinities and identify specific amino acid residues involved in hydrogen bonding.

Results

Identification of Core Targets

The intersection of cervical cancer DEGs, COVID-19-related genes, and autophagy-related genes revealed a cluster of ten core targets: CASP8, CFTR, DNMT1, HPSE, KCNH2, PIK3CA, PIK3R1, SERPINE1, TLR4, and VEGFA.

Identification of overlapping targets through differential expression analysis and Venn diagram intersection.

The PPI network analysis further illustrated the high degree of connectivity between these proteins, suggesting they function as a coordinated regulatory hub.

Detailed protein-protein interaction (PPI) network of the ten identified core genes.

Pathway Enrichment and Binding Affinity

KEGG analysis indicated that these targets are primarily involved in the PI3K-Akt signaling pathway and Toll-like receptor signaling, which are central to cell growth and immune defense. Molecular docking confirmed that laminarin binds spontaneously and stably to four key proteins, with significant negative binding energies (e.g., -8.4 kcal/mol for CASP8).

Structural validation identified specific residues, such as LYS-48 in VEGFA and ASP-687 in CASP8, as critical sites for hydrogen bonding with laminarin, providing a blueprint for the molecule's interaction at the atomic level.

Discussion

These findings suggest that laminarin acts as a dual-action agent. By targeting VEGFA, it may inhibit tumor angiogenesis and reduce lung inflammation associated with COVID-19. Simultaneously, its interaction with TLR4 suggests a role in modulating the innate immune response.

While these computational results are compelling, they represent a preliminary step. The study is limited by a lack of in vitro or in vivo validation. Furthermore, the bioavailability and metabolic stability of a large polysaccharide like laminarin in the human body require further investigation. Future work should focus on clinical verification and functional characterization in biological models to confirm laminarin's potential as a combined therapy for cervical cancer and COVID-19.

Summary updated

Abstract

Until today, the coronavirus disease 2019 (COVID-19) pandemic has caused 6,043,094 deaths worldwide, and most of the mortality cases have been related to patients with long-term diseases, especially cancer. Autophagy is a cellular process for material degradation. Recently, studies demonstrated the association of autophagy with cancer development and immune disorder, suggesting autophagy as a possible target for cancer and immune therapy. Laminarin is a polysaccharide commonly found in brown algae and has been reported to have pharmaceutic roles in treating human diseases, including cancers. In the present report, we applied network pharmacology with systematic bioinformatic analysis, including gene ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, reactome pathway analysis, and molecular docking to determine the pharmaceutic targets of laminarin against COVID-19 and cervical cancer <i>via</i> the autophagic process. Our results showed that the laminarin would target ten genes: <i>CASP8</i>, <i>CFTR</i>, <i>DNMT1</i>, <i>HPSE</i>, <i>KCNH2</i>, <i>PIK3CA</i>, <i>PIK3R1</i>, <i>SERPINE1</i>, <i>TLR4</i>, and <i>VEGFA</i>. The enrichment analysis suggested their involvement in cell death, immune responses, apoptosis, and viral infection. In addition, molecular docking further demonstrated the direct binding of laminarin to its target proteins, VEGFA, TLR4, CASP8, and PIK3R1. The present findings provide evidence that laminarin could be used as a combined therapy for treating patients with COVID-19 and cervical cancer.
BibTeX
@inproceedings{liu2022silico,
  author = {Jiaqi Liu and Yudong Chen and Litao Nie and Liang Xiao and Wenjun Huang and Rong Li},
  title = {{In silico analysis and preclinical findings uncover potential targets of anti-cervical carcinoma and COVID-19 in laminarin, a promising nutraceutical}},
  booktitle = {Frontiers in Pharmacology},
  year = {2022},
  doi = {10.3389/fphar.2022.955482},
}
Figure